Clinical trial
The Efficacy and Safety of Winlevi in Skin of Color Patients With Acne
NCT06415305 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Winlevi in Skin of Color Patients With Acne
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 1, 2023
- Completion date
- January 30, 2025
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.